Jefferies Starts ResMed (RMD) at Hold
Tweet Send to a Friend
Jefferies analyst Matthew Taylor initiates coverage on ResMed (NYSE: RMD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
